We understand the unique needs of patients living with chronic inflammatory demyelinating polyneuropathy (CIDP). Patients with CIDP often cope with impaired sensory function and weakness in the arms and legs. We understand that this disease can be challenging, as treatments may be successful for a time but relapses can still occur. However, with guidance and the right combination of corticosteroids, immune globulin therapy and/or immunosuppressants, patients can keep their symptoms under control. We’re here from diagnosis to recovery, with financial guidance, treatment education and 24/7 clinical support.
Chronic Inflammatory Demyelinating Polyneuropathy
One of the first steps after a chronic inflammatory demyelinating polyneuropathy (CIDP) diagnosis is understanding the condition. The information on this site and linked sites is not meant to replace your physician’s advice, medical care or a diagnosis. If you have questions about your disease, please ask your prescriber.
Chronic inflammatory demyelinating polyneuropathy occurs as a result of damage to the myelin sheath, the fatty covering that protects nerve fibers within the body. CIDP, also known as chronic relapsing polyneuropathy, results in muscles weakness and reduced sensitivity in extremities. Patients might experience tingling, numbness, fatigue and loss of deep tendon reflexes.
CIDP can occur at any time, but it is typically diagnosed in young adults. Males are more prone to experience CIDP than females.
The course of the disease varies, with some patients seeing spontaneous recovery while others suffer chronically. With the early treatment, people living with the disorder can go into remission and live without side effects for extended periods.
The information contained herein may not be construed as medical advice. It is for educational purposes only. Diplomat Pharmacy Inc. takes no responsibility for the accuracy or validity of the information contained herein, nor the claims or statements of any manufacturer.